{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:05:58Z","timestamp":1792404358736,"version":"4.4.0"},"reference-count":58,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Actinic keratoses (<jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>) arise on sun\u2010exposed regions of the skin. If left untreated, <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> may progress to invasive squamous cell carcinoma (<jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content>), although the rate of progression is low. A practical treatment algorithm for the treatment of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> in standard situations has been published by the <jats:styled-content style=\"fixed-case\">AKT<\/jats:styled-content>eam<jats:sup>\u2122<\/jats:sup> expert panel. However, management of particular situations of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> with increasing\/higher carcinoma risk or <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> progressing into carcinomas with increased aggressiveness due to their anatomical location (risky areas), or in patients with an increased risk of <jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content> requires further discussion. These include <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> on the dorsal hands, forearms, legs, periorbital region, eyelids, ears, or lips, and organ transplant recipients, patients undergoing treatment with carcinogenic agents and patients with chronic lymphocytic leukaemia. The main objective was to propose therapeutic strategies for the treatment of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> located in risky areas and in patients with more invasive\/aggressive lesions and a higher risk of progression to <jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content>. A systematic review of the literature was initially performed, and results were discussed by the experts to propose best management practices in specific situations. Finally, adapted management strategies for <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> occurring in risky areas and in high\u2010risk patients are presented, taking into account the experts\u2019 own clinical experience and current guidelines. In most of these \u2018at\u2010risk\u2019 situations, patients can be treated according to the <jats:styled-content style=\"fixed-case\">AKT<\/jats:styled-content>eam<jats:sup>\u2122<\/jats:sup> treatment algorithm. Difficult\u2010to\u2010treat lesions should be treated more aggressively due to their higher risk of transformation. For patients with skin that is highly susceptible to actinic damage, monitoring and sun protection strategies are mandatory, and patients should undergo more regular follow\u2010up. Further assessment of newer therapies in clinical trials is necessary to determine optimal treatment conditions. This expert consensus provides guidance for the management of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> in risky body sites and in patients with an increasing\/higher risk for <jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content>s.<\/jats:p>","DOI":"10.1111\/jdv.14753","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T06:42:44Z","timestamp":1513147364000},"page":"339-346","source":"Crossref","is-referenced-by-count":31,"title":["Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the <scp>AKT<\/scp>eam\u2122 of expert clinicians"],"prefix":"10.1111","volume":"32","author":[{"given":"M. A.","family":"Richard","sequence":"first","affiliation":[{"name":"Dermatology Department UMR 911 INSERM CRO2 \u201cCenter for Research in Biological Oncology and Oncophamacology\u201d Timone Hospital Public Hospitals of Marseille Aix\u2010Marseille University Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Amici","sequence":"additional","affiliation":[{"name":"Private Office of dermatology Rive Droite Cenon France"},{"name":"Dermatology Department H\u00f4pital Saint\u2010Andre Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Basset\u2010Seguin","sequence":"additional","affiliation":[{"name":"Dermatology Department H\u00f4pital Saint\u2010Louis AP\u2010HP Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Claudel","sequence":"additional","affiliation":[{"name":"Private Office of Dermatology Tours France"},{"name":"Dermatology Department CHU Clocheville Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[{"name":"Dermatology Department H\u00f4pitaux Universitaires de Strasbourg Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dreno","sequence":"additional","affiliation":[{"name":"Department of Dermato cancerology University Hospital Hotel Dieu Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12420"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12434"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04296.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14970"},{"key":"e_1_2_8_6_1","first-page":"16","article-title":"An investigator\u2010initiated study to assess the safety and efficacy of ingenol mebutate 0.05% gel when used after cryosurgery in the treatment of hypertrophic actinic keratosis on dorsal hands","volume":"9","author":"Hashim PW","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_7_1","first-page":"36","article-title":"An investigator\u2010initiated study to assess the safety and efficacy of imiquimod 3.75% cream when used after cryotherapy in the treatment of hypertrophic actinic keratoses on dorsal hands and forearms","volume":"6","author":"Goldenberg G","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13935"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10337.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318257f5f2"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.04.002"},{"key":"e_1_2_8_12_1","first-page":"938","article-title":"Photodynamic therapy as a response to the challenge of treating actinic keratosis in the eyelid area","volume":"103","author":"Toledo\u2010Alberola F","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e3182467c68"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318224ae9b"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/01676830903294909"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70178-5"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1679-45082016AO3578"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153848"},{"key":"e_1_2_8_19_1","first-page":"1","article-title":"Management of actinic cheilitis using ingenol mebutate gel: a report of seven cases","volume":"28","author":"Florez A","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12188"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1039\/c2pp25125f"},{"key":"e_1_2_8_22_1","first-page":"99","article-title":"Methyl\u2010aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients","volume":"147","author":"Fai D","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962012000300011"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13542"},{"key":"e_1_2_8_25_1","first-page":"1290","article-title":"Erbium laser resurfacing for actinic cheilitis","volume":"12","author":"Cohen JL","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000254"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13911"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.062"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra022137"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.063"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15019"},{"key":"e_1_2_8_32_1","first-page":"830","article-title":"Actinic keratoses, actinic field change and associations with squamous cell carcinoma in renal transplant recipients in Manchester, UK","volume":"95","author":"Wallingford SC","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_33_1","unstructured":"Meda Pharmaceuticals Ltd.Efudix cream. 5% w\/w fluorouracil. Summary of Product Characteristics. URLhttps:\/\/www.medicines.org.uk\/emc\/medicine\/6219. Updated 10\/11\/2016 (last accessed 19 June 2017)."},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04356.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12507"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13222"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11051.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000589"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3621"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13863"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12329"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12041"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81758-6"},{"key":"e_1_2_8_44_1","first-page":"274","article-title":"Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment","volume":"196","author":"Salmon\u2010Ehr V","year":"1998","journal-title":"Dermatology"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2000.00311.x"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.11"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00909.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.09.033"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.362"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12165"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04520.x"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12350.x"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.07.050"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12111"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90352-6"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13261"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.08.055"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.24586"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05982.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T10:06:01Z","timestamp":1695549961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/jdv.14753"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14753","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]}}}